Abstract: The instant invention relates to mesogenic systems comprising a) a polymeric component, component A, obtained or obtainable from polymerisation of a precursor comprising one or more mesogenic mono-reactive compounds, one or more di-reactive compounds, which optionally are also mesogenic compounds and optionally a photo-initiator and a low molecular weight component, component B, comprising one or more mono-reactive, mesogenic compounds, one or more mesogenic compounds and one or more chiral dopants, exhibiting a Blue Phase, as well as to the use of these systems in deices and to these devices.
Type:
Grant
Filed:
March 13, 2013
Date of Patent:
February 14, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Cecile Schott, John Patrick, Kevin Adlem, Louise Farrand, Georg Bernatz, Achim Goetz, Peter Best, Herbert Plach
Abstract: The invention relates to compounds of the formula I in which R1 and X1 have the meanings indicated in claim 1, and to a liquid-crystalline medium comprising at least one compound of the formula I, and to the use thereof in electro-optical liquid-crystal displays, in particular in TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS or PS-FFS-, positive VA displays and in shutter spectacles for 3D effects and LC lenses.
Type:
Application
Filed:
August 4, 2016
Publication date:
February 9, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Achim GOETZ, Christian HOCK, Lars LIETZAU, Mark GOEBEL
Abstract: The present invention relates to a liquid-crystalline medium (LC medium), to the use thereof for electrooptical purposes and to LC displays comprising this medium.
Type:
Application
Filed:
August 5, 2016
Publication date:
February 9, 2017
Applicant:
Merck Patent GmbH
Inventors:
Harald HIRSCHMANN, Michael WITTEK, Renate SEEGER, Brigitte SCHULER, Martina WINDHORST, Christian HOCK, Volker REIFFENRATH
Abstract: An apparatus (10; 20; 30; 40; 60) for removing moisture from a surface (522) in a container (500; 5001, 5002; 500?), characterized by: a centrifuging element comprising a mount (140; 1401, 1402) for attaching said container (500; 5001, 5002; 500?) to said centrifuging element and a drive (105) coupled to said mount (140; 1401, 1402) for rotating said attached container (500; 5001, 5002; 500?) and centrifuging said moisture off said surface (522) in said attached container (500; 5001, 5002; 500?); and a heating element (200) for providing heat energy and evaporating said moisture from said surface (522) in said attached container (500; 5001, 5002; 500?), and a corresponding method.
Abstract: The present application relates to a liquid-crystalline material which comprises at least one dye compound and at least one compound of a formula (IA) or (IB). The liquid-crystalline material is suitable for use in optical switching devices, in particular in devices for the homogeneous regulation of the passage of light through an area.
Type:
Application
Filed:
March 20, 2015
Publication date:
February 2, 2017
Applicant:
Merck Patent GmbH
Inventors:
Michael JUNGE, Mila FISCHER, Ursula PATWAL, Peer KIRSCH, Susann BECK
Abstract: The present invention provides a method of producing a liquid crystal display device which enables suppression of the occurrence of an electric double layer on a horizontal photo-alignment film before a polymer is formed, and exhibits reduced deterioration of display quality such as image sticking, or reduced display unevenness. The present invention is a method of producing a liquid crystal display device including the steps of (1) forming a liquid crystal layer containing a polymerizable monomer between a first substrate and a second substrate; (2) thermally annealing the liquid crystal layer at a temperature higher by 10° C. or more than the liquid crystalline phase-isotropic phase transition temperature of the liquid crystal layer; (3) forming horizontal alignment films to which the alignment treatment is performed by light irradiation on the first substrate and the second substrate by the time of the step (2); and (4) polymerizing the polymerizable monomer after the step (2).
Abstract: The invention relates to novel conjugated polymers comprising in their backbone one or more divalent donor units, like for example benzo[1,2-b:4,5-b?]dithiophene-2,6-diyl (BDT), that are linked on both sides to an acceptor unit, to methods of preparing the polymers and educts or intermediates used in such preparation, to polymer blends, mixtures and formulations containing the polymers, to the use of the polymers, polymer blends, mixtures and formulations as semiconductors organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.
Type:
Grant
Filed:
February 15, 2013
Date of Patent:
January 31, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Nicolas Blouin, Amy Phillips, Lana Nanson, Steven Tierney, Toby Cull, Priti Tiwana, Stephane Berny, Miguel Carrasco-Orozco, Frank Egon Meyer
Abstract: The invention relates to novel polymers containing repeating units based on benzo[1,2-d;4,3-d?]bisthiazole, monomers and methods for their preparation, their use as semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers.
Type:
Grant
Filed:
September 21, 2011
Date of Patent:
January 31, 2017
Assignee:
Merck Patent GmbH
Inventors:
William Mitchell, Mansoor D'Lavari, Steven Tierney, Nicolas Blouin, Thorsten Schwalm
Abstract: The present invention relates to polymerizable mixtures and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type.
Type:
Grant
Filed:
June 30, 2011
Date of Patent:
January 31, 2017
Assignee:
Merck Patent GmbH
Inventors:
Achim Goetz, Sven Christian Laut, Andreas Taugerbeck
Abstract: The invention is directed to the treatment of prostate cancer by means of antibodies. Above all, the invention relates to the administration of an anti-alpha-v integrin (receptor) antibody to patients suffering from prostate cancer, especially castration-resistant prostate cancer (CRPC), optionally accompanied by lymph node and bone tissue metastases (mCRPC). In particular, the invention relates to the therapy of said patients by means of the anti-angiogenic antibody DI17E6 and structural mutants thereof.
Type:
Grant
Filed:
February 7, 2012
Date of Patent:
January 31, 2017
Assignee:
Merck Patent GmbH
Inventors:
Axel Hoffmann, Heinrich Lannert, Klaus Brischwein, Frederic Christian Pipp, Juergen Reindl, Karin Groll, Michael Zuehlsdorf, Otmar Pfaff, Sabine Raab, Ulrike Dau, Benoit Destenaves
Abstract: A light emitting device is presented. The device comprises an array of pixels and an electrode arrangement, wherein said array of pixels comprises pixels of first and second groups comprising first and second pluralities of light emitting nanorods aligned along first and second predetermined axes respectively, the axes being substantially perpendicular to each other, and the pixels of said array are associated with a plurality of electrode elements of said electrode arrangement thereby enabling modulation of optical emission of one or more pixels separately from one or more other pixels of said pixel array by controllable application of an electric field, the device being therefore configured and operable as an active pixel emitter.
Type:
Grant
Filed:
May 9, 2012
Date of Patent:
January 31, 2017
Assignees:
Merck Patent GmbH, Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd., Qlight Nanotech, Ltd.
Abstract: The present invention relates to the preparation and use of recombinant variants of group 6 allergens of the Poaceae (true grasses), which are characterized by reduced IgE reactivity compared with known wild-type allergens and at the same time substantially retained reactivity with T-lymphocytes.
Type:
Grant
Filed:
November 21, 2014
Date of Patent:
January 31, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Helmut Fiebig, Andreas Nandy, Roland Suck, Oliver Cromwell, Arnd Petersen, Wolf-Meinhard Becker
Abstract: The present invention relates to organic electronic devices, and more specifically to organic field effect transistors, comprising a dielectric layer that comprises a polycycloolefinic polymer with an olefinic side chain.
Type:
Application
Filed:
February 13, 2015
Publication date:
January 26, 2017
Applicants:
PROMERUS, LLC, MERCK PATENT GMBH
Inventors:
LARRY F RHODES, CRYSTAL D CYRUS, HUGH A BURGOON, IRINA AFONINA, TOBY CULL
Abstract: Method, kit and composition for analyzing analytes for modifications using modification site specific antibodies to bind an analyte with his specific modification sites of interest to different dyes simultaneously with an antibody which is specific to the non-modificated analyte binding to another dye to determine the concentration of the analyte for quantification of the modified analyte in the identical sample.
Type:
Application
Filed:
February 27, 2015
Publication date:
January 26, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Frank JEAHRLING, Friedhelm BLADT, Jessica WITZGALL
Abstract: A fluid transfer device comprising a first reservoir (1) having a predetermined sub-ambient pressure and volume and a presealed opening (1a), a second reservoir (2) containing a predetermined volume of a fluid (M) and having a presealed opening (2a), and a chamber (3) having an internal space (6) and an inlet (4) to the space (6) adapted to be connected to the opening (2a) of the second reservoir (2) and an outlet (5) from the space (6) adapted to be connected to the opening (1a) of the first reservoir (1).
Abstract: The present invention relates to an improved electrodeionization (EDI) module and apparatus adapted to transfer ions present in a liquid under the influence of an electric field.
Abstract: The present invention relates to compounds of formula (I) Wherein R1, R2, R3, R4, L and Z have the meaning given in claim 1, and their use in the prophylaxis and treatment of diseases.
Abstract: The invention describes electronic devices comprising a metal complex compound having at least one tetradentate ligand having N and/or P donors, in particular a ligand having a PPPP, NNNN, PNNP or NPPN structure, and uses of a complex of this type in the electronic field and for the generation of light.
Type:
Grant
Filed:
July 18, 2012
Date of Patent:
January 24, 2017
Assignee:
Merck Patent GmbH
Inventors:
Lars Wesemann, Hermann August Mayer, Hartmut Schubert, Sophie Wernitz
Abstract: The present invention relates to nematic liquid-crystal media of negative dielectric anisotropy which have a peak time (tmax.) of 0.25 ms or less, which is determined as described in the disclosure, and which preferably have a value of the quotient of the peak time and the square of the birefringence (tmax/?n2) of 22 ms or less, and to the use of these liquid-crystal media in liquid-crystal displays, and to these liquid-crystal displays.
Type:
Grant
Filed:
June 13, 2005
Date of Patent:
January 24, 2017
Assignee:
Merck Patent GmbH
Inventors:
Melanie Klasen-Memmer, Izumi Saito, Herbert Plach, Kazuaki Tarumi
Abstract: The present invention relates to the use of compounds of the formula (I) for the care, preservation or improvement of the general condition or appearance of the skin or hair, and to preparations comprising compounds of the formula (I).